Pharmaceutics, Free Full-Text

Labetalol is a drug that exhibits both alpha and beta-adrenergic receptor-blocking properties. The American Heart Association/American Stroke Association (AHA/ASA) has recommended labetalol as an initial treatment option for the management of severe hypertension. The physiologically based pharmacokinetic (PBPK) model is an in silico approach to determining the pharmacokinetics (PK) of a drug by incorporating blood flow and tissue composition of the organs. This study was conducted to evaluate the primary reasons for the difference in PK after intravenous (IV) and oral administration in healthy and diseased (renal and hepatic) populations. A comprehensive literature search was done using two databases, PubMed and Google Scholar. Various PK parameters were screened for the development of the PBPK model utilizing a population-based PK-Sim simulator. Simulations were performed after creating building blocks firstly in healthy individuals and then in diseased patients after IV and oral administration. The disposition of labetalol after IV and oral administration occurring in patients with the hepatic and renal disease was predicted. The model was evaluated by calculating the Robs/pred ratio and average fold error (AFE), which was in the two-fold error range. Moreover, Box-whisker plots were made to compare the overall concentration of the drug in the body at various stages of disease severity. The presented model provides useful quantitative estimates of drug dosing in patients fighting against severe chronic diseases.

Home Page: American Journal of Pharmaceutical Education

Belsa Pharmaceuticals

PDF) Pharmaceutics book

Drug Development and Industrial Pharmacy: Vol 49, No 11 (Current issue)

Overcoming Barriers to Pharma Market Access in Emerging Markets, Request a FREE Proposal From Infiniti's Pharma Industry Experts for Detailed Insights

REMfresh Melatonin Sleep Supplement, Drug-Free, Pills to Support Natural Sleep, #1

Frontiers Publishing Partnerships on X: In a new @CanadaCSPS 🍁 JPPS paper, @UAlberta_Pharm researchers, including @sherifelezaby review the #pharmacokinetic and #pharmacodynamic effects of inflammation on drug metabolism. 💊 Read and download the

Top 50 deficiencies in CTD Dossier - Pharmaceutical

Drug Development and Industrial Pharmacy: Vol 49, No 11 (Current issue)

A Comprehensive Review of the Role of Complementary and Dietary Medicines in Eradicating Helicobacter pylori, Iranian Journal of Pharmaceutical Research

Pure D Ribose Powder, 1 KG (2.2 Pound and 200 Servings), Natural Simple Sugar, Dissolves Clear, Pharmaceutical Grade, Filler Free, No GMOs, No Gluten. and Water Soluble : Health & Household